S SHACKELFORD PHARMA

Owner

Goods & Services

(Based on Intent To Use) Pharmaceutical preparations for treating neurological diseases and disorders; pharmaceutical preparations for treating headaches, neurodegeneration, neurogenesis, epilepsy, childhood epilepsy, paediatric encephalopathies, pain, cancer, managing the effects of chemotherapy, Tourette Syndrome, post-traumatic stress disorder (PTSD), nausea, vomiting, premenstrual syndrome (PMS), neurologic conditions, sleep disorders, cognitive decline, facial pain, spasms, gastrointestinal diseases, rare diseases, Alzheimer's disease, appetite loss, cancer, Crohn's disease, anorexia, bulimia, epilepsy, glaucoma, schizophrenia, multiple sclerosis, muscle spasms, nausea, pain, headaches, wasting syndrome (cachexia), and diseases classified as "orphan" by the US Food and Drug Administration

(Based on 44(d) Priority Application) (Based on Intent to Use) Providing consumer, business and industry information to the public in the fields of medical cannabis, the treatment of medical conditions, and research in the field of medical marijuana

(Based on 44(d) Priority Application) (Based on Intent to Use) Providing information to the public in the field of scientific and medical research in the field of medical marijuana; Providing information to the public in the field of scientific and medical research in the field of neurological diseases and disorders